Maintenance IV Ketamine Therapy in the Fibromyalgia Patient: A Case Report
# Introduction Fibromyalgia is a complex disorder characterized by distributed and persistent pain often associated with fatigue and depression. The underlying causal agents of this dysfunction are not clear. Ketamine has been used to treat chronic pain in a variety of pain syndromes, including fib...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Open Medical Publishing
2023-11-01
|
| Series: | Health Psychology Research |
| Online Access: | https://doi.org/10.52965/001c.89640 |
| _version_ | 1797372128344932352 |
|---|---|
| author | Ruchir Gupta Supurna Bhar |
| author_facet | Ruchir Gupta Supurna Bhar |
| author_sort | Ruchir Gupta |
| collection | DOAJ |
| description | # Introduction
Fibromyalgia is a complex disorder characterized by distributed and persistent pain often associated with fatigue and depression. The underlying causal agents of this dysfunction are not clear. Ketamine has been used to treat chronic pain in a variety of pain syndromes, including fibromyalgia, but the dosing protocols used are neither standardized nor consistent across cases. The current case presents an opportunity to contribute to a progression towards a consensus on ketamine dosing for fibromyalgia.
# Case Presentation
A 60-year-old female presented with indications of fibromyalgia and was administered a 9-session IV ketamine treatment for pain. The initial dosing was 50 mg, with a concentration of 1.0 mg/ml at an infusion rate of 0.8 mg/kg/hr. This was increased to 200 mg and eventually to 240 mg, maintaining a ketamine concentration 4.0--4.8 mg/ml at an infusion rate of 1.5 mg/kg/hr.
# Management and Outcomes
Following the first 9-session therapy, the patient reported \>50% pain relief from pre-infusion levels and was placed on a maintenance regimen in perpetuity. This regimen involves two monthly IV ketamine infusions, one day apart for two hours at a maintenance rate of 4.8 mg/kg/hr.
# Conclusion
Ketamine by IV is an effective option for pain management in patients with fibromyalgia. Compared to previous case studies, it is recommended that increased total dose, frequent administration, and longer duration of infusions all may be necessary for ketamine to maximize its beneficial effects. |
| first_indexed | 2024-03-08T18:30:25Z |
| format | Article |
| id | doaj.art-170cb8bd31a84271aedfd048e4d280d9 |
| institution | Directory Open Access Journal |
| issn | 2420-8124 |
| language | English |
| last_indexed | 2024-03-08T18:30:25Z |
| publishDate | 2023-11-01 |
| publisher | Open Medical Publishing |
| record_format | Article |
| series | Health Psychology Research |
| spelling | doaj.art-170cb8bd31a84271aedfd048e4d280d92023-12-30T03:34:03ZengOpen Medical PublishingHealth Psychology Research2420-81242023-11-0111Maintenance IV Ketamine Therapy in the Fibromyalgia Patient: A Case ReportRuchir GuptaSupurna Bhar# Introduction Fibromyalgia is a complex disorder characterized by distributed and persistent pain often associated with fatigue and depression. The underlying causal agents of this dysfunction are not clear. Ketamine has been used to treat chronic pain in a variety of pain syndromes, including fibromyalgia, but the dosing protocols used are neither standardized nor consistent across cases. The current case presents an opportunity to contribute to a progression towards a consensus on ketamine dosing for fibromyalgia. # Case Presentation A 60-year-old female presented with indications of fibromyalgia and was administered a 9-session IV ketamine treatment for pain. The initial dosing was 50 mg, with a concentration of 1.0 mg/ml at an infusion rate of 0.8 mg/kg/hr. This was increased to 200 mg and eventually to 240 mg, maintaining a ketamine concentration 4.0--4.8 mg/ml at an infusion rate of 1.5 mg/kg/hr. # Management and Outcomes Following the first 9-session therapy, the patient reported \>50% pain relief from pre-infusion levels and was placed on a maintenance regimen in perpetuity. This regimen involves two monthly IV ketamine infusions, one day apart for two hours at a maintenance rate of 4.8 mg/kg/hr. # Conclusion Ketamine by IV is an effective option for pain management in patients with fibromyalgia. Compared to previous case studies, it is recommended that increased total dose, frequent administration, and longer duration of infusions all may be necessary for ketamine to maximize its beneficial effects.https://doi.org/10.52965/001c.89640 |
| spellingShingle | Ruchir Gupta Supurna Bhar Maintenance IV Ketamine Therapy in the Fibromyalgia Patient: A Case Report Health Psychology Research |
| title | Maintenance IV Ketamine Therapy in the Fibromyalgia Patient: A Case Report |
| title_full | Maintenance IV Ketamine Therapy in the Fibromyalgia Patient: A Case Report |
| title_fullStr | Maintenance IV Ketamine Therapy in the Fibromyalgia Patient: A Case Report |
| title_full_unstemmed | Maintenance IV Ketamine Therapy in the Fibromyalgia Patient: A Case Report |
| title_short | Maintenance IV Ketamine Therapy in the Fibromyalgia Patient: A Case Report |
| title_sort | maintenance iv ketamine therapy in the fibromyalgia patient a case report |
| url | https://doi.org/10.52965/001c.89640 |
| work_keys_str_mv | AT ruchirgupta maintenanceivketaminetherapyinthefibromyalgiapatientacasereport AT supurnabhar maintenanceivketaminetherapyinthefibromyalgiapatientacasereport |